Publications
Export 9 results:
Filters: Author is Malla, Ashok [Clear All Filters]
“Short communication: Prevalence of long-acting injectable antipsychotic use in Canadian early intervention services for psychosis.”, J Psychiatr Res, vol. 165, pp. 77-82, 2023.
“[Early Intervention for Psychosis from Past to Future: Overcoming Implementation Challenges to Maximize its Impact?].”, Sante Ment Que, vol. 46, no. 2, pp. 391-415, 2021.
, “What Is the Place of Clozapine in the Treatment of Early Psychosis in Canada?”, Can J Psychiatry, vol. 62, no. 2, pp. 109-114, 2017.
, “An Exploratory, Open-Label, Randomized Trial Comparing Risperidone Long-Acting Injectable with Oral Antipsychotic Medication in the Treatment of Early Psychosis.”, Clin Schizophr Relat Psychoses, vol. 9, no. 4, pp. 198-208, 2016.
, “Long-acting injectable antipsychotics: evidence of effectiveness and use.”, Can J Psychiatry, vol. 58, no. 5 Suppl 1, p. 5S-13S, 2013.
, “Long-acting injectable antipsychotics: recommendations for clinicians.”, Can J Psychiatry, vol. 58, no. 5 Suppl 1, p. 30S-5S, 2013.
, “A qualitative study of experiences with and perceptions regarding long-acting injectable antipsychotics: part II-physician perspectives.”, Can J Psychiatry, vol. 58, no. 5 Suppl 1, p. 23S-9S, 2013.
, “A qualitative study of experiences with and perceptions regarding long-acting injectable antipsychotics: Part I-patient perspectives.”, Can J Psychiatry, vol. 58, no. 5 Suppl 1, p. 14S-22S, 2013.
, “Fronto-temporal disconnectivity and clinical short-term outcome in first episode psychosis: a DTI-tractography study.”, J Psychiatr Res, vol. 45, no. 3, pp. 369-77, 2011.
